Skip to main content
Premium Trial:

Request an Annual Quote

To the Top

US Food and Drug Administration officials, including Commissioner Margaret Hamburg, knew about the agency's email surveillance efforts, reports The Wall Street Journal. After reports of email monitoring came to light, Reuters reported that Senator Chuck Grassley (R-Iowa) asked FDA to detail who at the agency ordered the surveillance.

In a letter to Congress, FDA officials say the surveillance came about as a way to prevent leaks. After information about a medical device was leaked to the media, Jeffrey Shuren, who directs the medical device center at FDA, asked Ruth McKee, an associate director of that center, to look into how to prevent such leaks. McKee turned to the chief information officer of the agency, Lori Davis, who then requested the email monitoring, the Journal says. Hamburg and other officials were informed of the monitoring after it began. The surveillance focused on researchers who raised safety issues.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.